Immediate Impact
2 by Nobel laureates 20 from Science/Nature 66 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
A pan-cancer single-cell panorama of human natural killer cells
2023 Standout
Works of Per-Anders Broliden being referenced
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Per-Anders Broliden | 162 | 90 | 253 | 246 | 226 | 7 | 557 | |
| J A Strauchen | 52 | 78 | 128 | 116 | 194 | 18 | 627 | |
| J Goldman | 40 | 40 | 255 | 137 | 157 | 14 | 634 | |
| Gemma Pidelaserra-Martí | 30 | 34 | 349 | 90 | 89 | 7 | 622 | |
| GS Wood | 36 | 14 | 210 | 102 | 239 | 15 | 485 | |
| Lydia M. Evans | 22 | 58 | 260 | 85 | 240 | 16 | 635 | |
| Karim Abbed | 76 | 42 | 244 | 67 | 41 | 11 | 584 | |
| LE Silberstein | 27 | 22 | 227 | 142 | 99 | 12 | 607 | |
| Lyda M. Osorio | 138 | 55 | 265 | 121 | 52 | 15 | 555 | |
| Knowles Dm | 17 | 20 | 181 | 122 | 305 | 9 | 462 | |
| Lindi Tan | 240 | 146 | 163 | 69 | 77 | 8 | 574 |
All Works
Loading papers...